DD297838A5 - Verfahren zum einfuehren von genetischen einheiten in die zelle - Google Patents

Verfahren zum einfuehren von genetischen einheiten in die zelle Download PDF

Info

Publication number
DD297838A5
DD297838A5 DD90338709A DD33870990A DD297838A5 DD 297838 A5 DD297838 A5 DD 297838A5 DD 90338709 A DD90338709 A DD 90338709A DD 33870990 A DD33870990 A DD 33870990A DD 297838 A5 DD297838 A5 DD 297838A5
Authority
DD
German Democratic Republic
Prior art keywords
rna
ribozyme
genetic
genetic unit
trna
Prior art date
Application number
DD90338709A
Other languages
German (de)
English (en)
Inventor
Hartmut Beug
Max L Birnstiel
Matthew Cotten
Ernst Wagner
Harald Kandolf
Original Assignee
��������@���������������@����������������������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@���������������@����������������������@���k�� filed Critical ��������@���������������@����������������������@���k��
Publication of DD297838A5 publication Critical patent/DD297838A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD90338709A 1989-03-16 1990-03-14 Verfahren zum einfuehren von genetischen einheiten in die zelle DD297838A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT60989 1989-03-16

Publications (1)

Publication Number Publication Date
DD297838A5 true DD297838A5 (de) 1992-01-23

Family

ID=3495118

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90338709A DD297838A5 (de) 1989-03-16 1990-03-14 Verfahren zum einfuehren von genetischen einheiten in die zelle

Country Status (20)

Country Link
EP (1) EP0387775B1 (fr)
JP (1) JP3330930B2 (fr)
KR (1) KR900014591A (fr)
AT (1) ATE140961T1 (fr)
AU (1) AU637354B2 (fr)
CA (1) CA2012312C (fr)
DD (1) DD297838A5 (fr)
DE (1) DE59010432D1 (fr)
DK (1) DK0387775T3 (fr)
ES (1) ES2090049T3 (fr)
FI (1) FI105103B (fr)
GR (1) GR3020935T3 (fr)
HU (2) HU215187B (fr)
IE (1) IE74850B1 (fr)
IL (1) IL93754A (fr)
NO (1) NO306623B1 (fr)
NZ (1) NZ232917A (fr)
PT (1) PT93440B (fr)
RU (1) RU2136751C1 (fr)
ZA (1) ZA901973B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471796A4 (en) * 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
DE4091533T (fr) * 1989-08-31 1992-01-30
JP2507895B2 (ja) * 1989-12-19 1996-06-19 工業技術院長 リボザイムの新規合成系
CA2084790C (fr) * 1990-06-19 2002-04-09 Philip Anthony Jennings Endonucleases
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
DE69123979T2 (de) 1990-10-12 1997-04-30 Max Planck Gesellschaft Abgeänderte ribozyme
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
FR2687411A1 (fr) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn.
AU4259193A (en) * 1992-04-28 1993-11-29 Frank Andreas Harald Meyer Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
AU687001B2 (en) * 1992-05-14 1998-02-19 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting cancer development
US5989906A (en) * 1992-05-14 1999-11-23 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
US5610052A (en) * 1992-08-26 1997-03-11 Ribozyme Pharmaceuticals Inc. Enzymatic RNA with activity to ras
JPH06509719A (ja) * 1992-05-27 1994-11-02 シティ・オブ・ホープ キメラｔＲＮＡＬＹＳ−リボザイム分子
US5827935A (en) * 1992-05-27 1998-10-27 City Of Hope Chimeric tRNAlys -ribozyme molecules
ATE312510T1 (de) * 1992-06-29 2005-12-15 Gene Shears Pty Ltd Nukleinsäuren und sie verwendende verfahren zur bekämpfung viraler pathogene
AU5968994A (en) * 1992-12-16 1994-07-04 Johanna E. Bergmann Agents for the prevention and treatment of human alzheimer's disease
EP0647716B1 (fr) * 1993-07-06 2003-09-24 Universite De Nice-Sophia Antipolis Vecteur comportant un gène viral transcrit par l'ARN polymérase III
US5837503A (en) * 1993-07-07 1998-11-17 Universite De Nice-Sophia-Antipolis Vector containing viral gene transcribed by RNA polymerase III and methods for use
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
WO1995019788A1 (fr) * 1994-01-24 1995-07-27 City Of Hope Co-localisation d'une molecule cible et de ses inhibiteurs
DE4424761C1 (de) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expressionskassette für die Antisense- und die Ribozym-Expression
NZ308970A (en) 1995-06-07 1999-10-28 Commw Scient Ind Res Org Optimized minizymes and miniribozymes and uses thereof
FR2755976B1 (fr) * 1996-11-15 1999-01-15 Idm Immuno Designed Molecules Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
US6057156A (en) 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
WO1999020753A2 (fr) * 1997-10-21 1999-04-29 Ribozyme Pharmaceuticals, Inc. Formation de liaison peptidique utilisant des catalyseurs d'acide nucleique
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
SK287538B6 (sk) 1998-03-20 2011-01-04 Commonwealth Scientific And Industrial Research Organisation Syntetický gén obsahujúci dispergovanú alebo cudzorodú deoxyribonukleovú molekulu, génový konštrukt obsahujúci tento syntetický gén a prípravok obsahujúci tento syntetický gén
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (fr) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods

Also Published As

Publication number Publication date
NO901213L (no) 1990-09-17
IE74850B1 (en) 1997-08-13
AU5130190A (en) 1990-11-01
IE900931L (en) 1990-09-16
RU2136751C1 (ru) 1999-09-10
KR900014591A (ko) 1990-10-24
HUT54206A (en) 1991-01-28
HU211868A9 (en) 1995-12-28
EP0387775B1 (fr) 1996-07-31
EP0387775A1 (fr) 1990-09-19
JP3330930B2 (ja) 2002-10-07
FI901296A0 (fi) 1990-03-15
HU901584D0 (en) 1990-06-28
CA2012312A1 (fr) 1990-09-16
DK0387775T3 (da) 1996-11-04
NO901213D0 (no) 1990-03-15
GR3020935T3 (en) 1996-12-31
FI105103B (fi) 2000-06-15
NZ232917A (en) 1997-07-27
ATE140961T1 (de) 1996-08-15
JPH03130080A (ja) 1991-06-03
IL93754A (en) 1995-12-31
HU215187B (hu) 1998-10-28
PT93440B (pt) 2001-07-31
DE59010432D1 (de) 1996-09-05
PT93440A (pt) 1990-11-07
ZA901973B (en) 1991-11-27
CA2012312C (fr) 2001-08-14
NO306623B1 (no) 1999-11-29
ES2090049T3 (es) 1996-10-16
AU637354B2 (en) 1993-05-27
IL93754A0 (en) 1990-12-23

Similar Documents

Publication Publication Date Title
EP0387775B1 (fr) Unité génétique pour inhiber la fonction d'ARN
EP0388758B1 (fr) Conjugé protéine-polycation
DE69233117T2 (de) In sich geschlossende "sens-" und "antisense"-oligonukleotide und deren verwendungen
DE3852539T3 (de) Ribozyme.
DE69636937T2 (de) Durch trans-spaltung erhaltene therapeutische molekule
DE69634698T2 (de) Gewebespezifische und ziel-rna-spezifische ribozyme
DE69729292T2 (de) Kurze externe führungssequenzen
DE69034238T2 (de) Verfahren zur Erreichung einer Expression, oder zur Verbesserung der Expression eines Gens
DE69433034T2 (de) Expression von heterologen genen nach einem ziel-expressionsprofil
DE3486053T3 (de) Regulierung von Gen-Expression durch Translationshemmung unter Verwendung von m-RNS hinderndem Komplementär-RNS.
EP1798285B1 (fr) Méthode et médicament destinés à inhiber l'expression d'une gène donnée
DE69333550T2 (de) TNF-alpha RIBOZYME UND ABBAU-RESISTENTE mRNA DERIVATIVE GEBUNDEN AN TNF-alpha Ribozyme
DE69729145T2 (de) Reagenz und Verfahren zur Inhibierung der N-RAS Expression
DE4338704A1 (de) Stabilisierte Oligonucleotide und deren Verwendung
WO2003062423A2 (fr) Procede d'inhibition de l'expression d'un gene cible issu d'une aberration chromosomique
DE60221572T2 (de) Kontrolle der genexpression durch verwendung eines komplexes aus einem oligonucleotid und einem regulatorischen peptid
EP0986642B1 (fr) Acides nucleiques antisens diriges contre le virus de l'hepatite b
WO2003022858A2 (fr) Procede de criblage d'inhibiteurs de l'interaction proteine-proteine, et ribozymes utilises a cet effet
DE69432444T2 (de) Promotor-Sequenz des Rezeptors p55 für Tumor-Nekrosis-Faktor
EP1259263B1 (fr) Complexation d'arn, notamment de ribozymes, avec des polyethylenimines pour sa stabilisation et son introduction cellulaire
EP0299303B1 (fr) Vecteurs d'expression eucaryotiques avec des sous-unités "enhancer" multimériques, procédé pour la préparation et utilisation
US6830923B1 (en) Genetics units for inhibiting the function of RNA
DE102004038535B4 (de) Zelluläre Einschleusung von Nukleinsäurewirkstoffen
WO1997004087A1 (fr) Ribozymes pour l'inhibition selective de l'expression de genes d'alleles du complexe majeur d'histocompatibilite(cmh), et medicaments les contenant
DE60127687T2 (de) Testverfahren zur bestimmung der alternativen verlangerung von telomeren in menschlichen zellen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee